AMR Logo.png
Global Fluoroscopy Equipment Market To Garner $6.50 Billion By 2028: Allied Market Research
June 24, 2021 09:30 ET | Allied Market Research
Portland, OR, June 24, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Fluoroscopy Equipment Market generated $4.07 billion in 2020, and is estimated...
InCarda Logo.png
InCarda Therapeutics Announces Positive End-of-Phase 2 Meeting with FDA for InRhythm™ for Treatment of Atrial Fibrillation
June 23, 2021 08:05 ET | InCarda Therapeutics, Inc.
Single Pivotal Phase 3 Trial in Atrial Fibrillation Acceptable to Support Filing of New Drug Application Company on Track to Initiate Phase 3 RESTORE1 Study in Q3 2021 with Data Expected 2H 2022 ...
CVRx Logo_R_RGB_black.png
CVRx® Announces First Clinical Procedure with a New Ultrasound-Guided Implant Approach, the Latest Advancement in Barostim™ for the Treatment of Heart Failure Symptoms
June 10, 2021 11:19 ET | CVRx, Inc.
MINNEAPOLIS, June 10, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced the completion of the...
researchdrivelogo.jpg
Global Medical Device Manufacturing Outsourcing Market Predicted to Garner a Revenue of $104.3 Million at a CAGR of 10.3% during the Forecast Period, 2019-2026 - Exclusive Report [Pages-215] by Research Dive
June 09, 2021 09:36 ET | Research Dive
New York, USA, June 09, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global medical device manufacturing outsourcing market is projected to register a revenue...
Reports and Data.jpeg-01
Computer Aided Detection (CAD) Market to Reach USD 1579.5 Million In 2028 | Reports and Data
June 09, 2021 09:00 ET | Reports and Data
New York, June 09, 2021 (GLOBE NEWSWIRE) -- Rising prevalence of chronic diseases and growing demand for computational assistance are key factors surging global market growth  Market size: USD...
InCarda Logo.png
InCarda Therapeutics Provides Corporate Update Highlighting New Phase 2 Data for InRhythm™ Program, Plans for Pivotal Phase 3 Study and Expansion of Senior Management Team
June 09, 2021 08:05 ET | InCarda Therapeutics, Inc.
Positive Data from Completed InRhythm Phase 2 Study Demonstrate Safe and Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Plans to Initiate RESTORE1: Single Pivotal Phase 3 Trial in...
researchdrivelogo.jpg
Global Medical Tourism Market Expected to Generate a Revenue of $142.2 Billion at a CAGR of 11.7% during the Forecast Period, 2019-2026 – Exclusive Report [150 Pages] By Research Dive
June 08, 2021 08:37 ET | Research Dive
New York, US, June 08, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global medical tourism market is forecasted to reach $142.2 billion by the end of 2026, from $58.6...
TIP_link_300x300.jpg
Medical Devices Market Growth Sturdy at 6.1% CAGR to Outstrip $767,684.9 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
April 26, 2021 12:30 ET | The Insight Partners
Pune, India., April 26, 2021 (GLOBE NEWSWIRE) -- Medical Devices Market: Key InsightsAccording to our new research study on “Medical Devices Market to 2027 – Global Analysis and Forecast – by...
Inotiv_Logo_CMYK.png
Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology
March 17, 2021 08:33 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., March 17, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of...
Fierce Medtech Names CVRx as One of its “Fierce 15” Companies
March 15, 2021 10:00 ET | CVRx, Inc.
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announces it has been selected...